NCT05594849View on ClinicalTrials.gov

Evaluation of Efficacy, Safety and Patient' Satisfaction of Therapeutic Switch From Off-Steroids to Budesonide

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Eosinophilic Esophagitis
Interventions
DRUG

Budesonide Orodispersible Tablets (Jorveza)

Patients that swith to Budesonide Orodispersible Tablets (Jorveza)

Trial Locations (1)

20089

Department of Gastroenterology, Humanitas Research Hospital, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER